Sentosa SQ HIV-1 genotyping assay reagents

Ended Purchase Order Awarded

Contract number
75D30122P13718
Awardee
Awarding agency
Obligated
$99,340

Award facts

Contract value 100% obligated
$99,339.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30341, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This federal contract award, with an ID of 75D30122P13718, was made by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. for the provision of SENTOSA SQ HIV-1 GENOTYPING ASSAY REAGENTS. The contract has a firm fixed price of $99,339.90 and a completion date of May 31, 2023. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions for infectious diseases and cancer, and this award supports the CDC's critical public health initiatives through the provision of leading diagnostic technologies and associated equipment, supplies, and services. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75D30122P13718?

75D30122P13718 was awarded to Vela Diagnostics USA Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 21, 2022.

How much is contract 75D30122P13718 worth?

The government has obligated $99,340 on 75D30122P13718.

Was contract 75D30122P13718 competed?

The extent of competition for 75D30122P13718 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login